| Product Name | HLA-DR, HLA-DP + HLA-DQ antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Mouse monoclonal [CR3/43] to HLA DR + DP + DQ |
| Immunogen | Immunogen sequence information is commercially sensitive and details are not available |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Clone Number | CR3/43 |
| Host Species | Mouse |
| Tested Applications | IHC-P |
| For IHC-P: Use at a dilution of 1:25-1:50 in an ABC method. Optimal dilutions/concentrations should be determined by the end user.: |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Target | HLA-DR, HLA-DP + HLA-DQ |
|---|---|
| Tissue Specificity | Reacts with the beta chain of all products of the gene sub regions DP, DQ, and DR. It stains B cells, interdigitating reticulum cells, Langerhans cells and many macrophages. This antibody does not react with normal T cell and polymorphs but stains activated T cells. |
| Cellular Localization | Cell Membrane |
| Light Chain Type | kappa |
| Positive Control | Tonsil |
|---|---|
| Application Notes | For IHC-P: Use at a dilution of 1:25-1:50 in an ABC method. Optimal dilutions/concentrations should be determined by the end user.: |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution, aliquot and store at 4°C. |
| Storage Buffer | Tissue culture supernatant containing 0.1% sodium azide |
